Found: 13
Select item for more details and to access through your institution.
Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 284, doi. 10.1007/s002800050042
- By:
- Publication type:
- Article
Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 345, doi. 10.1007/s002800050050
- By:
- Publication type:
- Article
Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 320, doi. 10.1007/s002800050047
- By:
- Publication type:
- Article
Effect of high-dose cyclosporine on etoposide pharmacodynamics in a trial to reverse P-glycoprotein (MDR1 gene) mediated drug resistance.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 305, doi. 10.1007/s002800050045
- By:
- Publication type:
- Article
A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 265
- By:
- Publication type:
- Article
Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 273, doi. 10.1007/s002800050040
- By:
- Publication type:
- Article
Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 312, doi. 10.1007/s002800050046
- By:
- Publication type:
- Article
N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 329, doi. 10.1007/s002800050048
- By:
- Publication type:
- Article
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 291
- By:
- Publication type:
- Article
Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 4, p. 335, doi. 10.1007/s002800050049
- By:
- Publication type:
- Article